4
Changes in Ownership
Lexaria Bioscience Corp. Filed Acc 0001103780-20-000004
CEO bought 195,500 shares at an average $0.20 ($39,769)
From the SEC's structured data for this filing
Trades in this filing
BUNKA CHRISTOPHER · CEO
Table I: Non-derivative
10 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-11-06 | Purchase : show line 1 in the form | +60,000 | $0.21 | $12,306 | 6,341,844 | I |
| 2020-11-09 | Purchase : show line 2 in the form | +37,500 | $0.22 | $8,063 | 6,379,344 | I |
| 2020-11-09 | Purchase : show line 3 in the form | +10,000 | $0.20 | $2,025 | 6,389,344 | I |
| 2020-11-09 | Purchase : show line 4 in the form | +10,000 | $0.21 | $2,129 | 6,399,344 | I |
| 2020-11-09 | Purchase : show line 5 in the form | +8,000 | $0.20 | $1,600 | 6,407,344 | I |
| 2020-11-09 | Purchase : show line 6 in the form | +6,500 | $0.20 | $1,307 | 6,413,844 | I |
| 2020-11-09 | Purchase : show line 7 in the form | +22,000 | $0.20 | $4,391 | 6,435,844 | I |
| 2020-11-10 | Purchase : show line 8 in the form | +10,000 | $0.20 | $1,950 | 6,445,844 | I |
| 2020-11-10 | Purchase : show line 9 in the form | +6,000 | $0.20 | $1,199 | 6,451,844 | I |
| 2020-11-10 | Purchase : show line 10 in the form | +25,500 | $0.19 | $4,799 | 6,477,344 | I |
| Open-market purchases · 195,500 sh · avg $0.20 · $39,769 | ||||||
Loading xslF345X03/primary_doc.xml…